Literature DB >> 6116903

Multiply resistant pneumococcus causing meningitis: its epidemiology within a day-care centre.

M S Radetsky, G R Istre, T L Johansen, S W Parmelee, B A Lauer, A M Wiesenthal, M P Glode.   

Abstract

An 11 month-old infant had meningitis caused by a strain of Streptococcus pneumoniae, serotype 6b, resistant to penicillin, chloramphenicol, and several other antimicrobials. The minimum inhibitory concentrations (MIC) by agar dilution were 1.0 microgram/ml for penicillin and 16 microgram/ml for chloramphenicol. The infant did not respond to high-dose intravenous penicillin G but was cured by a combination of ampicillin, chloramphenicol, and rifampicin. At the infant's day-care centre this multiply resistant strain was isolated from throat cultures of 27% of the children (age less than or equal to 26 months) assigned to the same room as the index case, and from 11% of older children and staff. There was a 33% carriage rate in family contacts of colonised children. Antibiotic use during the previous 2 months was more frequent among the carriers than among non-carriers. No resistant pneumococci were found in on hundred and twenty-five children and staff in six other Denver day-care centres, in 300 consecutive routine throat cultures processed by our clinical microbiology laboratory, or among 150 pneumococcal isolates collected from Denver area hospitals. The carriers were not treated, and there have been no other cases of infection due to this strain. The emergence of multiply resistant pneumococci in the United States indicates the need to screen important pneumococcal isolates for resistance to both penicillin and chloramphenicol, especially in cases of meningitis.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6116903     DOI: 10.1016/s0140-6736(81)90184-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  31 in total

Review 1.  Strategies for promoting judicious use of antibiotics by doctors and patients.

Authors:  E A Belongia; B Schwartz
Journal:  BMJ       Date:  1998-09-05

2.  Meningitis and pneumonia due to novel multiply resistant pneumococci.

Authors:  K P Klugman; H J Koornhof; V Kuhnle; S D Miller; P J Ginsburg; A C Mauff
Journal:  Br Med J (Clin Res Ed)       Date:  1986-03-15

3.  Penicillin-resistant pneumococcus.

Authors:  G D Corcoran; T F Buckley; C Connor; L Clancy; C T Keane
Journal:  Ir J Med Sci       Date:  1988-01       Impact factor: 1.568

Review 4.  World-wide development of antibiotic resistance in pneumococci.

Authors:  P C Appelbaum
Journal:  Eur J Clin Microbiol       Date:  1987-08       Impact factor: 3.267

Review 5.  Pneumonia--1987: new developments.

Authors:  F M LaForce
Journal:  Eur J Clin Microbiol       Date:  1987-12       Impact factor: 3.267

6.  Cefotaxime in pneumococcal meningitis.

Authors:  H Lecour; A Seara; A M Miranda; J Cordeiro
Journal:  Infection       Date:  1985       Impact factor: 3.553

7.  Cefotaxime monotherapy of bacterial meningitis caused by gram-positive pathogens.

Authors:  H F Helwig
Journal:  Infection       Date:  1985       Impact factor: 3.553

8.  Comparison of antimicrobial susceptibility methods for detection of penicillin-resistant Streptococcus pneumoniae.

Authors:  D L Kiska; A Kerr; M C Jones; N N Chazotte; B Eskridge; S Miller; M Jordan; C Sheaffer; P H Gilligan
Journal:  J Clin Microbiol       Date:  1995-01       Impact factor: 5.948

9.  Cross-reacting opsonic antibodies to clinically important pneumococcal serotypes after pneumococcal vaccination.

Authors:  J H Braconier; E B Myhre; H Odeberg
Journal:  Eur J Clin Microbiol       Date:  1983-10       Impact factor: 3.267

Review 10.  Narrow versus broad spectrum antibacterials: factors in the selection of pneumococcal resistance to beta-lactams.

Authors:  Claude Carbon; Raul Isturiz
Journal:  Drugs       Date:  2002       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.